Farmakoterapia w Psychiatrii i Neurologii

Full text

1/2022 vol. 38
Original article

Relationships between the pharmacological treatment method and negative symptoms, depression, social functioning and quality of life in schizophrenia patients during 11–15 years after a first psychiatric hospitalisation

Krystyna Jaracz 1
,
Krystyna Górna 2
,
Justyna Kiejda 2
,
Katarzyna Gołębiewska 2
,
Jan Jaracz 3
  1. Department of Neurological Nursing, Poznan University of Medical Sciences, Poznan, Poland;
    Zakład Pielęgniarstwa Neurologicznego, Uniwersytet Medyczny w Poznaniu, Polska
  2. Department of Psychiatric Nursing, Poznan University of Medical Sciences, Poznan, Poland;
    Zakład Pielęgniarstwa Psychiatrycznego, Uniwersytet Medyczny w Poznaniu
  3. Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland;
    Klinika Psychiatrii Dorosłych, Uniwersytet Medyczny w Poznaniu, Polska
Farmakoterapia w Psychiatrii i Neurologii 2022, 38 (1), 23–33
DOI: https://doi.org/10.5114/fpn.2022.117698
Data publikacji online: 2022/08/02
Article file
02R_IPiN_FARM_2022-1C.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry. Suppl. 1993; 22: 39-44.
  2. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990;157: 853-859.
  3. Bobes J, Arango C, Garcia-Garcia M, Rejas J. CLAMORS Study Collaborative Group. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry 2010; 71(3): 280-286.
  4. Bucci P, Mucci A, van Rossum IW, Aiello C, Arango C, Baandrup L i wsp. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning. Eur Neuropsychopharmacol 2020; 34: 76-86.
  5. Cerveri G, Gesi C, Mencacci C. Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm. Neuropsychiatr Dis Treat 2019; 15: 1525-1535.
  6. Correll CU, Schooler NR. Negative symptoms in schizophrenia: A review and clinical guide for recognition, assessment, and treatment. Neuropsychiatr Dis Treat 2020; 16: 519-534.
  7. Galderisi S, Kaiser S, Bitter I, Nordentoft M, Mucci A, Sabé M i wsp. EPA guidance on treatment of negative symptoms in schizophrenia. Eur Psychiatry 2021; 64(1): e21. (a)
  8. Galderisi S, Mucci A, Dollfus S, Nordentoft M, Falkai P, Kaiser S i wsp. EPA guidance on assessment of negative symptoms in schizophrenia. Eur Psychiatry 2021; 1864(1): e23. (b)
  9. García-Fernández L, Romero-Ferreiro V, Sánchez-Pastor L, Dompablo M, Martínez-Gras I, Espejo-Saavedra JM i wsp. Impact of negative symptoms on functioning and quality of life in first psychotic episodes of schizophrenia. J Clin Med 2022; 11(4): 983.
  10. Górna K, Jaracz K, Jaracz J, Kiejda J, Grabowska-Fudala B, Rybakowski J. Funkcjonowanie społeczne i jakość życia u chorych na schizofrenię – zależność z remisją objawową i czasem trwania choroby. Psychiatr Pol. 2014; 48(2): 277-88.
  11. Górna K, Jaracz K, Rybakowski F, Rybakowski J. Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study. Qual Life Res. 2008; 17(2): 237-247.
  12. an der Heiden W, Leber A, Häfner H. Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2016; 266(5): 387-396.
  13. Jaracz J, Tetera-Rudnicka E, Kujath D, Raczyńska A, Stoszek S, Czernaś W i wsp. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland. Pharmacol Rep 2014; 66(4): 613-617.
  14. Jaracz K, Górna K, Kiejda J, Grabowska-Fudala B, Jaracz J, Suwalska A, Rybakowski JK. Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia. Eur Psychiatry 2015; 30(8): 907-913.
SUBMIT YOUR PAPER
Share
without publication fees
without publication fees
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications